Nicotine and Cannabis Explore thought-leadership and expert insights on the consumer behaviour, regulatory forces and cutting-edge innovation trends shaping the complex and rapidly developing nicotine and cannabis industries.

CVS’s Decision to Stop Selling Tobacco Will Have Minimal Industry Impact

2/10/2014
Shane MacGuill Profile Picture
Shane MacGuill Bio
Share:
 

 

CVS Caremark, the second largest pharmacy chain in the US, recently announced it would stop selling tobacco products in October 2014. Shane MacGuill, Tobacco Industry Analyst at Euromonitor, states that outside of a symbolic victory for tobacco control groups, this move will have little impact the tobacco market. Pharmacies only make up about three and a half percent of tobacco sales in the US, and CVS itself was responsible for only two percent of total US tobacco sales in 2012.

Watch on Youtube

Interested in more insights? Subscribe to our content

Latest Insights

CBD + Hemp Workshop

Euromonitor International 28 September 2022

Indonesia Tobacco: Key Findings in 2022

Aileen Supriyadi 06 September 2022

Shop Our Reports

Cigarettes in Western Europe

The pandemic caused notable behavioural change in most consumers, with government regulations contributing to disparate affects on the channel distribution,…

View Report

Global Inflation Tracker: Q3 2022

This report examines inflation levels and drivers globally and in key countries. Global inflation is reaching a peak, although geopolitical risks and…

View Report

What’s Happening in Tobacco? Q2 2022

This report examines the main news related to the tobacco industry for the second quarter of 2022. It covers key legislative announcements alongside prevalence…

View Report
Passport Our premier global market research database with detailed data and analysis on industries, companies, economies and consumers. Track existing and future opportunities to support critical decision-making across all functions within your organisation Learn More